Author: Section Editor: Deputy Editor
Author: Section Editor: Deputy Editor
Author: Section Editor: Deputy Editor
Contributor Disclosures
All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: Jul 2021. | This topic last updated: Oct 02, 2020.
INTRODUCTION
This topic will review the clinical manifestations, diagnosis, and treatment of conjunctivitis.
Other conditions which may be confused with conjunctivitis include acute angle-closure
glaucoma, iritis, uveitis, and infectious keratitis. In contrast to acute conjunctivitis, these
conditions are sight-threatening and must be managed by an ophthalmologist. They are
discussed elsewhere:
Bacterial conjunctivitis
Bacterial conjunctivitis is highly contagious and is spread by direct contact with the patient
and their secretions or with contaminated objects and surfaces. Outbreaks due to S.
pneumoniae have been described on college campuses and among military trainees [7,8].
transmitted from the genitalia to the hands and then to the eyes. Concurrent urethritis is
typically present.
The eye infection is characterized by a profuse purulent discharge present within 12 hours
of inoculation [10]; the amount of discharge is striking. Other symptoms are rapidly
progressive and include redness, irritation, and tenderness to palpation. There is typically
marked chemosis (conjunctival edema), lid swelling, and tender preauricular adenopathy.
Conjunctival scrapings should be sent for immediate Gram stain to identify gram-negative
diplococci. Polymerase chain reaction (PCR) can also be used for diagnosis of gonococcal
conjunctivitis [11].
Viral conjunctivitis
The second eye usually becomes involved within 24 to 48 hours, although unilateral signs
and symptoms do not rule out a viral process. Patients often believe that they have a
bacterial conjunctivitis that has spread to the fellow eye; they do not appreciate that this is
the ocular manifestation of a systemic illness, even if they are experiencing viral symptoms
at the same time.
On examination there is typically only mucoid discharge if one pulls down the lower lid or
looks very closely in the corner of the eye. Usually there is profuse tearing rather than
discharge. The tarsal conjunctiva may have a follicular or "bumpy" appearance ( picture 3
). There may be an enlarged and tender preauricular node.
Viral conjunctivitis is a self-limited process. The clinical course parallels that of the common
cold. While recovery can begin within days, the symptoms frequently get worse for the first
three to five days, with very gradual resolution over the following one to two weeks for a
total course of two to three weeks. Just as a patient with a cold can have morning coughing
and nasal congestion or discharge two weeks after symptoms first arise, patients with viral
conjunctivitis may have morning crusting two weeks after the initial symptoms, although
the daytime redness, irritation, and tearing should be much improved.
Conjunctivitis might accompany herpes simplex virus (HSV) keratitis, acute varicella zoster
(chickenpox), or herpes zoster ophthalmicus (V1 shingles), but the conjunctival process is
self-limited, requiring no treatment beyond what would be undertaken for the herpes
keratitis, for acute management of herpes zoster, or for management of chronic sequelae
of herpes zoster ophthalmicus.
It typically presents as bilateral redness, watery discharge, and itching ( picture 4).
Itching is the cardinal symptom of allergy, distinguishing it from a viral etiology, which is
more typically described as grittiness, burning, or irritation. Eye rubbing can worsen
symptoms. Patients with allergic conjunctivitis often have a history of atopy, seasonal
allergy, or specific allergy (eg, to cats), and other allergic symptoms (eg, nasal congestion,
sneezing, wheezing) may be present.
The clinical findings are the same as those seen in viral conjunctivitis. Both cause diffuse
injection with a bumpy or follicular appearance to the tarsal conjunctiva ( picture 3).
Some allergic conjunctivitis may present with larger papillary rather than follicular reaction.
There is profuse watery or mucoserous, stringy discharge, and both may have morning
crusting. It is the complaint of itching and the history of allergy or hay fever as well as a
recent exposure that distinguishes allergic conjunctivitis.
● Patients with dry eye may report chronic or intermittent redness or discharge and may
interpret these symptoms as being related to an infectious cause.
https://www.uptodate.com/contents/conjunctivitis?search=gonorrhea conjunctivitis&source=search_result&selectedTitle=1~150&usage_type=default&display… 5/20
8/23/2021 Conjunctivitis - UpToDate
● Patients whose eyes are irrigated after a chemical splash may have redness and
discharge; this is often related to the mechanical irritation of irrigation rather than
superinfection.
● A patient with an ocular foreign body that was spontaneously expelled may have
redness and discharge for 12 to 24 hours.
It is worthwhile to elicit the character of the ocular discharge, as patients may refer to
all discharge as “pus.” In bacterial conjunctivitis the complaint of discharge
predominates, while in viral and allergic conjunctivitis patients report a burning and
gritty feeling or itching.
A recent history of trauma should prompt investigation for etiologies other than
conjunctivitis.
A history of contact lens use should prompt specific evaluation for keratitis. (See
'Contact lens wearers' below.)
Warning signs for sight-threatening conditions should be excluded. (See 'Reasons for
urgent ophthalmologic referral' below.)
Certain features on history raise concern for more serious diagnoses and should
prompt ophthalmologic referral. These include photophobia, severe headache with
nausea, and severe foreign body sensation. (See 'Reasons for urgent ophthalmologic
referral' below.)
• If the conjunctival injection is localized rather than diffuse, another diagnosis such
as foreign body, pterygium, or episcleritis should be considered. (See "Pterygium"
and "Episcleritis".)
• If the tarsal conjunctiva is spared, suspicion should be raised for keratitis, iritis, and
angle-closure glaucoma. These serious conditions cause a red eye with 360 degree
involvement of the bulbar conjunctiva, often in a ciliary flush pattern, but without
tarsal conjunctival involvement. (See 'Reasons for urgent ophthalmologic referral'
below.)
The diagnosis of conjunctivitis can be made in a red eye if there is discharge, vision is
normal, and there is no evidence of keratitis, iritis, or angle-closure glaucoma (see "The red
eye: Evaluation and management"). In addition, on examination there should be no focal
pathology in the lids such as hordeolum (stye), nodular ulceration or mass suspicious for
neoplasia, or blepharitis (diffuse eyelid margin thickening and hyperemia with lash crusts) (
picture 5). In these other disorders, conjunctival hyperemia, if present, is reactive rather
than primary.
Certain features on examination raise concern for more serious diagnoses and should
prompt ophthalmologic referral. (See 'Reasons for urgent ophthalmologic referral' below.)
Limited role for testing — Cultures or stains are not necessary for the initial diagnosis
and therapy of conjunctivitis, and ophthalmologists typically do not generally perform
cultures even when they are referred cases that have not responded to initial therapy. The
exception is patients with signs and symptoms of hyperacute conjunctivitis in whom
Giemsa and Gram stains may be helpful to identify N. gonorrhoeae. (See 'Hyperacute
bacterial conjunctivitis' above.)
Swabbing for culture, stains, and direct antibody or polymerase chain reaction (PCR) testing
is typically reserved only for atypical or chronic cases that fail to improve or respond to
therapy.
● Ciliary flush – A pattern of injection in which the redness is most pronounced in a ring
at the limbus, (the transition zone between the cornea and the sclera). This is
concerning for infectious keratitis, iritis, and angle-closure glaucoma.
● Severe foreign body sensation that prevents the patient from keeping the eye open
(concerns about infectious keratitis).
Note that photophobia and severe foreign body sensation are also characteristic of corneal
abrasion, a condition that can be initially treated in the primary care or emergency care
setting, with referral to ophthalmology if symptoms persist. Corneal abrasion is
accompanied by tearing, but typically there is no discharge. (See "Corneal abrasions and
corneal foreign bodies: Management" and "Corneal abrasions and corneal foreign bodies:
Clinical manifestations and diagnosis".)
THERAPY
General considerations
Bacterial
Treatment options for acute bacterial conjunctivitis are presented in the table ( table 2).
Preferred choices include erythromycin ophthalmic ointment or trimethoprim-polymyxin B
drops. The dosing is 0.5 inch (1.25 cm) of erythromycin ointment deposited inside the lower
lid, or one to two drops of trimethoprim polymyxin B, four times daily for five to seven days
to the affected eye. These agents are preferred as they are inexpensive, widely available,
and non-toxic, and they have low rates of hypersensitivity. Common alternative therapies
include bacitracin ointment (limited by cost) and bacitracin-polymyxin B ointment (limited
by cost and patient sensitivity).
Ointment is preferred over drops for children, those with poor compliance, or those in
whom it is difficult to administer eye medications. Ointment stays on the lids and can have
therapeutic effect even if it is not clear that any of the dose was applied directly to the
conjunctiva. Because ointments blur vision for 20 minutes after the dose is administered,
drops are preferable for most adults who need to read, drive, and perform other tasks that
require clear vision immediately after dosing.
Patients should respond to treatment within one to two days by showing a decrease in
discharge, redness, and irritation. At this point it is reasonable to reduce the dose from four
times daily to twice daily. Patients who do not respond should be referred to an
ophthalmologist.
● Sulfacetamide ophthalmic drops are also available but are not a first-line option
because of the potential for rare but serious allergic events.
● Aminoglycoside drops and ointments are poor choices since they are toxic to the
corneal epithelium and can cause a reactive keratoconjunctivitis after several days of
use.
● Fluoroquinolones are not first-line therapy for routine cases of bacterial conjunctivitis
because of concerns regarding emerging resistance and cost. The exception is
conjunctivitis in a contact lens wearer due to the high incidence of Pseudomonas
infection.
Common conjuctivitis in contact lens wearers — For all contact lens wearers with
bacterial conjunctivitis, we suggest antibiotic treatment due to the increased risk of
keratitis and/or infection with gram-negative organisms. Fluoroquinolones are the
preferred agent to treat bacterial conjunctivitis in contact lens wearers due to the high
incidence of Pseudomonas infection. Patients should stop wearing contact lenses. If there is
any corneal opacity or suspicion of keratitis, the patient should be evaluated by an
ophthalmologist. Microbial keratitis is more likely if there is foreign body sensation or
reduced vision (see "Complications of contact lenses", section on 'Infectious keratitis')
Chronic conjunctivitis in a contact lens wearer is best addressed by a knowledgeable
optometrist or ophthalmologist.
If the diagnosis is bacterial conjunctivitis, contact lens wear can resume when the eye is
white and has no discharge for 24 hours after the completion of antibiotic therapy, or, in
the case of viral conjunctivitis, when the eye is white with no discharge. The lens case
should be discarded and the lenses subjected to overnight disinfection or replaced if
disposable.
https://www.uptodate.com/contents/conjunctivitis?search=gonorrhea conjunctivitis&source=search_result&selectedTitle=1~150&usage_type=default&displa… 11/20
8/23/2021 Conjunctivitis - UpToDate
Viral — There is no specific topical or systemic antiviral agents for the treatment of viral
conjunctivitis. Systemic antibiotic and antiviral therapies play no role.
Patients must be told that the eye irritation and discharge may get worse for three to five
days before getting better, that symptoms can persist for two to three weeks, and that use
of any topical agent (antibiotics or antihistamine/decongestant) for that duration might
result in irritation and toxicity, which can itself cause redness and discharge. Clinicians must
be wary of trying one agent after another in patients with viral conjunctivitis who are
expecting drugs to "cure" their symptoms. Patient education is often more effective than
prolonged or additional therapies for patients who experience improvement but
incomplete resolution of symptoms after a few days.
associated with corneal adverse effect in some susceptible patients, which may become
sight-threatening. (See "Allergic conjunctivitis: Clinical manifestations and diagnosis".)
Lubricant drops can be used as often as hourly for one to two days with no side effects. The
ointment provides longer-lasting relief but blurs vision; thus, many patients use the
ointment only at bedtime. It may be worthwhile to switch brands if a patient finds one
brand of drop or ointment irritating since each preparation contains different active
ingredients, vehicles, and preservatives.
Diagnoses to consider in patients with persistent symptoms include dry eye (see "Dry eye
disease"), medicamentosa (drug toxicity) (see "Toxic conjunctivitis"), pterygium (see
"Pterygium"), blepharoconjunctivitis (see "Blepharitis"), and adult inclusion conjunctivitis.
(See 'Chronic chlamydial infections' above.)
● Work/school – Clinicians are often asked to advise patients and families or caregivers
as to when it is safe to return to work or school. Bacterial and viral conjunctivitis are
both highly contagious and spread by direct contact with secretions or contact with
contaminated objects. Infected individuals should not share handkerchiefs, tissues,
towels, cosmetics, linens, or eating utensils. The safest approach to prevent spread to
others is to stay home until there is no longer any discharge, but this is not feasible for
most students and for those who work outside the home. Most daycare centers and
schools require that students receive 24 hours of topical therapy before returning to
school. Such therapy will probably reduce the transmission of conjunctivitis due to
bacterial infection but will do nothing to reduce the spread of viral infections.
We suggest advising patients to consider that their problem is like a cold, and their
decision to return to work or school should be similar to the one they would make in
that situation. Those who have contact with the very old, the very young, and immune-
compromised individuals should take care to avoid spread of infection from their eye
secretions to these susceptible people.
● Sports – For bacterial conjunctivitis, patients should not return to playing sports until
they have used an antibiotic for a minimum of 24 hours and had resolution of eye
drainage. Clearance to return to play for viral conjunctivitis depends on the sport.
Athletes who participate in sports that are individual and/or noncontact and which do
not involve shared equipment (eg, cross-country running) can return when they feel
able and can see clearly. If these athletes return before symptoms have resolved, they
should be advised not to touch their eyes and to wash their hands frequently. Athletes
who participate in contact sports, sports with shared equipment (eg, gymnastics), or
water-based sports may return to play once daytime discharge has abated, typically
after about five days.
UpToDate offers two types of patient education materials, “The Basics” and “Beyond the
Basics.” The Basics patient education pieces are written in plain language, at the 5th to 6th
grade reading level, and they answer the four or five key questions a patient might have
about a given condition. These articles are best for patients who want a general overview
and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces
are longer, more sophisticated, and more detailed. These articles are written at the 10th to
12th grade reading level and are best for patients who want in-depth information and are
comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to
print or e-mail these topics to your patients. (You can also locate patient education articles
on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)
● Basics topic (see "Patient education: Conjunctivitis (pink eye) (The Basics)")
● Beyond the Basics topics (see "Patient education: Conjunctivitis (pink eye) (Beyond the
Basics)" and "Patient education: Allergic conjunctivitis (Beyond the Basics)")
● The diagnosis of conjunctivitis is made in a patient with a red eye and discharge only if
the vision is normal and there is no evidence of keratitis, iritis, or angle-closure
glaucoma. Warning signs for alternative conditions that should prompt evaluation by
an ophthalmologist are discussed above. (See 'Reasons for urgent ophthalmologic
referral' above and 'Evaluation and diagnosis' above.)
For patients who select antibiotic treatment for bacterial conjunctivitis, we suggest
treatment with either erythromycin ophthalmic ointment (0.5 inch applied to the lower
lid) or trimethoprim-polymyxin drops (one to two drops) over alternative agents (Grade
2C). Either agent is administered four times daily for five to seven days. Ointment is
preferred over drops for children, those with poor compliance, and those in whom it is
difficult to administer eye medications. (See 'Bacterial' above.)
• For all contact lens wearers with bacterial conjunctivitis, we suggest antibiotic
treatment (Grade 2C). Fluoroquinolones are the preferred agent to treat bacterial
conjunctivitis in contact lens wearers due to the high incidence of Pseudomonas
infection. Patients should stop wearing contact lens. If there is any corneal opacity
or suspicion of keratitis, the patient should be evaluated by an ophthalmologist.
(See 'Common conjuctivitis in contact lens wearers' above.)
Patients who do not respond to antibiotic treatment within a few days should also be
referred to an ophthalmologist. (See 'Bacterial' above.)
REFERENCES
1. Weiss A, Brinser JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr 1993;
122:10.
2. Fitch CP, Rapoza PA, Owens S, et al. Epidemiology and diagnosis of acute conjunctivitis
at an inner-city hospital. Ophthalmology 1989; 96:1215.
3. Gigliotti F, Williams WT, Hayden FG, et al. Etiology of acute conjunctivitis in children. J
Pediatr 1981; 98:531.
4. Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment.
JAMA 2013; 310:1721.
5. Rietveld RP, ter Riet G, Bindels PJ, et al. Predicting bacterial cause in infectious
conjunctivitis: cohort study on informativeness of combinations of signs and
symptoms. BMJ 2004; 329:206.
6. Friedlaender MH. A review of the causes and treatment of bacterial and allergic
conjunctivitis. Clin Ther 1995; 17:800.
7. Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical
Streptococcus pneumoniae. N Engl J Med 2003; 348:1112.
8. Crum NF, Barrozo CP, Chapman FA, et al. An outbreak of conjunctivitis due to a novel
unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis
2004; 39:1148.
10. Wan WL, Farkas GC, May WN, Robin JB. The clinical characteristics and course of adult
gonococcal conjunctivitis. Am J Ophthalmol 1986; 102:575.
12. Roba LA, Kowalski RP, Gordon AT, et al. Adenoviral ocular isolates demonstrate
serotype-dependent differences in in vitro infectivity titers and clinical course. Cornea
1995; 14:388.
13. Azar MJ, Dhaliwal DK, Bower KS, et al. Possible consequences of shaking hands with
your patients with epidemic keratoconjunctivitis. Am J Ophthalmol 1996; 121:711.
14. Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic
keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 1993;
167:1307.
15. Sambursky R, Tauber S, Schirra F, et al. The RPS adeno detector for diagnosing
adenoviral conjunctivitis. Ophthalmology 2006; 113:1758.
16. Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for
adenoviral conjunctivitis. Am J Med Sci 2008; 336:254.
17. Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact-lens-associated
microbial keratitis and its related morbidity. Lancet 1999; 354:181.
18. Tabbara KF, El-Sheikh HF, Aabed B. Extended wear contact lens related bacterial
keratitis. Br J Ophthalmol 2000; 84:327.
19. Wilkins MR, Khan S, Bunce C, et al. A randomised placebo-controlled trial of topical
steroid in presumed viral conjunctivitis. Br J Ophthalmol 2011; 95:1299.
21. Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin 1992;
10:505.
22. Rose PW, Harnden A, Brueggemann AB, et al. Chloramphenicol treatment for acute
infective conjunctivitis in children in primary care: a randomised double-blind placebo-
controlled trial. Lancet 2005; 366:37.
23. Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute
bacterial conjunctivitis. Cochrane Database Syst Rev 2012; :CD001211.
24. Ophthalmic azithromycin (AzaSite). Med Lett Drugs Ther 2008; 50:11.
25. Fraunfelder FW, Fraunfelder FT. Restricting topical ocular chloramphenicol eye drop
use in the United States. Did we overreact? Am J Ophthalmol 2013; 156:420.
26. Friedlaender MH. The current and future therapy of allergic conjunctivitis. Curr Opin
Ophthalmol 1998; 9:54.
27. Ciprandi G, Buscaglia S, Cerqueti PM, Canonica GW. Drug treatment of allergic
conjunctivitis. A review of the evidence. Drugs 1992; 43:154.